Bupa has launched a pandemic flu treatment service which will help companies to protect their employees against the effects of pandemic flu.
The Bupa Wellness service will give employees access to anti-viral treatments, support for business planning and information for employees about the risks of pandemic flu and what they need to do.
Bupa says the UK is at a heightened risk of pandemic flu due to the increasing spread of avian flu.
A report from the World Bank in 2005 estimates that pandemic flu could cost developed nations $550bn.
Bupa Wellness head of specialist services Martyn Anthony says: “During a pandemic there is likely to be widespread disruption to business, so it is vital that companies have a contingency plan in place. Bupa’s service means businesses can quickly arrange treatment with an effective anti-viral such as Tamiflu to as many employees as possible.”